Indications And Dose
Iron-deficiency anaemia ▶BY INTRAVENOUS INJECTION ▶Adult: (consult product literature)
PDF page 1102
Loading InternPractice…
Drug reference
Iron-deficiency anaemia ▶BY INTRAVENOUS INJECTION ▶Adult: (consult product literature)
PDF page 1102
Scottish Medicines Consortium (SMC) decisions The Scottish Medicines Consortium has advised (February 2017) that iron (III) isomaltoside 1000 5% (Diafer ®) is accepted for use within NHS Scotland for the treatment of iron deficiency in adults with chronic kidney disease on dialysis, when oral iron preparations are ineffective or cannot be used. The advice is contingent upon the continuing availability of the patient access scheme in NHS Scotland or a list price that is equivalent or lower.
PDF page 1103
→Appendix 1: iron (injectable)
PDF page 1103
▶Uncommon Fishbane reaction. infection ▶Rare or very rare Dysphonia
PDF page 1103
Avoid in first trimester.
PDF page 1103
Manufacturer advises caution in compensated hepatic disease—monitor iron status to avoid iron overload; avoid in decompensated hepatic disease, in hepatitis and where iron overload is a precipitating factor (particularly porphyria cutanea tarda).
PDF page 1103
There can be variation in the licensing of different medicines containing the same drug. Solution for injection ▶Diafer (Pharmacosmos UK Ltd) A Iron (as Iron isomaltoside 1000) 50 mg per 1 ml Diafer 100mg/2ml solution for injection ampoules | 25 ampoule P £423.75 ▶Monofer (Pharmacosmos UK Ltd) A Iron (as Iron isomaltoside 1000) 100 mg per 1 ml Monofer 500mg/5ml solution for injection vials | 5 vial P £423.75 Monofer 100mg/1ml solution for injection vials | 5 vial P £84.75 Monofer 1g/10ml solution for injection vials | 2 vial P £339.00 eiiii F 1079
PDF page 1103
(consult product literature)
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1102